2 results
Approved WMORecruiting
Substudy A: The primary objective will be to investigate the relationships between HPA axis dysfunction, early life adversity (ELA), and epigenetic mechanisms. Furthermore, this substudy will function to select participants for substudy B. Secondary…
Approved WMOCompleted
The purpose of this multi-cohort study is to assess the safety and efficacy of tusamitamab ravtansine (SAR408701) in mBC and mPAC participants with CEACAM5 positive tumors which are known to be sensitive to taxanes.